BRYAN K KEE to Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications BRYAN K KEE has written about Phosphatidylinositol 3-Kinases.
Connection Strength
0.050
-
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers. ESMO Open. 2021 10; 6(5):100230.
Score: 0.030
-
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget. 2015 May 20; 6(14):12809-21.
Score: 0.020